These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of glucocorticoids on circulating levels and hepatic expression of insulin-like growth factor (IGF)-binding proteins and IGF-I in the adrenalectomized streptozotocin-diabetic rat. Unterman TG; Jentel JJ; Oehler DT; Lacson RG; Hofert JF Endocrinology; 1993 Dec; 133(6):2531-9. PubMed ID: 7694841 [TBL] [Abstract][Full Text] [Related]
4. Growth hormone secretagogues stimulate the hypothalamic-pituitary-adrenal axis and are diabetogenic in the Zucker diabetic fatty rat. Clark RG; Thomas GB; Mortensen DL; Won WB; Ma YH; Tomlinson EE; Fairhall KM; Robinson IC Endocrinology; 1997 Oct; 138(10):4316-23. PubMed ID: 9322945 [TBL] [Abstract][Full Text] [Related]
5. An insulin-like growth factor I-resistant state in cartilage of diabetic rats is ameliorated by hypophysectomy. Possible role of metabolism. Kelley KM; Russell SM; Matteucci ML; Nicoll CS Diabetes; 1993 Mar; 42(3):463-9. PubMed ID: 8432417 [TBL] [Abstract][Full Text] [Related]
6. Cortisone arrests growth but enhances the inductive effect of porcine growth hormone on plasma IGF-I concentrations in female rats. Sillence MN; Etherton TD J Anim Sci; 1991 Jul; 69(7):2815-21. PubMed ID: 1885393 [TBL] [Abstract][Full Text] [Related]
7. Growth promotion by insulin-like growth factor I in hypophysectomized and diabetic rats. Zapf J Mol Cell Endocrinol; 1998 May; 140(1-2):143-9. PubMed ID: 9722182 [TBL] [Abstract][Full Text] [Related]
8. Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes. Kim E; Sohn S; Lee M; Jung J; Kineman RD; Park S J Endocrinol; 2006 Feb; 188(2):263-70. PubMed ID: 16461552 [TBL] [Abstract][Full Text] [Related]
9. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats. Cox GN; McDermott MJ; Merkel E; Stroh CA; Ko SC; Squires CH; Gleason TM; Russell D Endocrinology; 1994 Nov; 135(5):1913-20. PubMed ID: 7525258 [TBL] [Abstract][Full Text] [Related]
10. Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-I-binding protein-3, but not GH receptor gene expression in livers of juvenile rats. Domené H; Krishnamurthi K; Eshet R; Gilad I; Laron Z; Koch I; Stannard B; Cassorla F; Roberts CT; LeRoith D Endocrinology; 1993 Aug; 133(2):675-82. PubMed ID: 7688291 [TBL] [Abstract][Full Text] [Related]
11. Differential long-term effects of insulin-like growth factor-I (IGF-I) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats. Fielder PJ; Mortensen DL; Mallet P; Carlsson B; Baxter RC; Clark RG Endocrinology; 1996 May; 137(5):1913-20. PubMed ID: 8612531 [TBL] [Abstract][Full Text] [Related]
12. Corticosterone regulation of insulin-like growth factor I, IGF-binding proteins, and growth in streptozotocin-induced diabetic rats. Rodgers BD; Strack AM; Dallman MF; Hwa L; Nicoll CS Diabetes; 1995 Dec; 44(12):1420-5. PubMed ID: 7589849 [TBL] [Abstract][Full Text] [Related]
13. Modulation of brain insulin-like growth factor I (IGF-I) binding sites and hypothalamic GHRH and somatostatin levels by exogenous growth hormone and IGF-I in juvenile rats. Eshet R; Gil-Ad I; Apelboym O; Segev Y; Phillip M; Werner H J Mol Neurosci; 2004; 22(3):179-88. PubMed ID: 14997011 [TBL] [Abstract][Full Text] [Related]
14. Growth, body composition, and endocrine responses to chronic administration of insulin-like growth factor I and(or) porcine growth hormone in pigs. Klindt J; Yen JT; Buonomo FC; Roberts AJ; Wise T J Anim Sci; 1998 Sep; 76(9):2368-81. PubMed ID: 9781493 [TBL] [Abstract][Full Text] [Related]
15. Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rat. Luo JM; Murphy LJ Endocrinology; 1989 Jul; 125(1):165-71. PubMed ID: 2737140 [TBL] [Abstract][Full Text] [Related]
16. Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-C/insulin-like growth factor I and liver GH receptors in hypophysectomized rats. Maiter D; Underwood LE; Maes M; Davenport ML; Ketelslegers JM Endocrinology; 1988 Aug; 123(2):1053-9. PubMed ID: 3396497 [TBL] [Abstract][Full Text] [Related]
17. Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem? Halldin MU; Tylleskär K; Hagenäs L; Tuvemo T; Gustafsson J Clin Endocrinol (Oxf); 1998 Jun; 48(6):785-94. PubMed ID: 9713569 [TBL] [Abstract][Full Text] [Related]
18. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver. Maiter D; Walker JL; Adam E; Moatsstaats B; Mulumba N; Ketelslegers JM; Underwood LE Endocrinology; 1992 Jun; 130(6):3257-64. PubMed ID: 1375898 [TBL] [Abstract][Full Text] [Related]
19. Pioglitazone inhibits the diabetogenic action of growth hormone, but not its ability to promote growth. Towns R; Kostyo JL; Colca JR Endocrinology; 1994 Feb; 134(2):608-13. PubMed ID: 8299559 [TBL] [Abstract][Full Text] [Related]
20. Effects of the amino-terminal portion of human growth hormone on glucose clearance and metabolism in normal, diabetic, hypophysectomized, and diabetic-hypophysectomized rats. Salem MA Endocrinology; 1988 Sep; 123(3):1565-76. PubMed ID: 3042372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]